Effect of Nalbuphine and Naloxone on Experimentally Induced Skin Sensitivity
Effect of Kappa Opioid Agonist-Antagonists in the Heat/Capsaicin Sensitization Model
Sponsor: University of California, San Francisco
Terminated
Experimental pain model didn't work as anticipated.
Other terminated trials from University of California, San Francisco
- Hypertension · Phase PHASE2 · Jan 2026
- Menstrual Irregularity · Phase PHASE4 · Sep 2025
- Diabetes Mellitus, Type 2 · Phase NA · Feb 2025
- Asthma · Phase PHASE4 · Feb 2025
- Stone, Kidney · Phase NA · Dec 2024
See all terminations from University of California, San Francisco
A NA clinical study on Healthy, this trial is terminated or withdrawn. The trial is conducted by University of California, San Francisco and has accumulated 9 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Dec 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 4 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Feb 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .